Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”

Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”

Bibliographic Details
Main Authors: Jan Olof G. Karlsson, Per Jynge, Ingemar Lundström, Louis J. Ignarro
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Trials
Online Access:http://link.springer.com/article/10.1186/s13063-019-3476-3

Internet

http://link.springer.com/article/10.1186/s13063-019-3476-3

Similar Items